Clinical Trial Update: Safety of Tetanus, Diphtheria, Acellular Pertussis With 5 Acellular Pertussis Components (Tdap5) Vaccination During Pregnancy

View source ↗

Summary

This clinical trial update reports on the safety of the Tdap5 vaccine administered during pregnancy; the study is active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pertussis

Drugs mentioned

• Tdap5 vaccine (Tetanus, Diphtheria, Acellular Pertussis with 5 components)

Snippet

Sponsor: Sanofi | Conditions: Pertussis (Whooping Cough) | Status: ACTIVE_NOT_RECRUITING